BICO GROUP ABBICO GROUP ABBICO GROUP AB

BICO GROUP AB

No trades
See on Supercharts

49Z fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. It operates through the following segments: Bioprinting, Biosciences, Bioautomation, and Group. The Bioprinting segment includes 3D bioprinters and bioinks with a wide range of technologies for different demanding applications, resolutions, and volume and speed requirements, as well as services focused on accelerating drug discovery and development with advanced tissue imaging and cell culture services. The Biosciences segment focuses on supplying advanced lab instrumentation and smart workflow connectivity software to analyze data from applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics such as genomics. The Bioautomation segment offers scientific instruments and solutions for scalable manufacturing of diagnostics, as well as consumables to enable single-cell and other workflows. The Group segment is involved in the group’s administration and shareholder costs. The company was founded by Erik Paul Gatenholm and Hector Daniel Martinez Avila in March 2015 and is headquartered in Gothenburg, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

49Z does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company